Hailing from South Korea, Letybo is the sixth and most recent neuromodulator approved by the FDA. Here, dermatologists unpack ...

Allergan PLC’s multibillion-dollar Botox franchise is once again under attack from new competitors, threatening a core business at a time when the drugmaker is already battling other challenges.

But to dodge that deadline, Allergan is using another strategy; let's call it the "stay small and make weird products" approach. The company behind Botox, the "face-lift in a bottle," is itself ...

For the second time in less than a year, the Food and Drug Administration has warned Irvine-based Allergan Inc. that advertisements for its anti-wrinkle drug Botox are misleading and should be pulled.

Allergan pushes "Botox parties" that put people at risk of HIV and hepatitis because a "single-use" vial of the drug is used multiple times on different guests, according to a federal lawsuit ...

Misty Keasler / The New York Times-Redux Because of Botox I don't have any wrinkles," says Allergan CEO David Pyott, whose 58-year-old forehead is as smooth as an aging Hollywood starlet's ...

Allergan Inc., maker of the wrinkle smoother Botox, said second-quarter profit rose 6.9% as overseas sales of facial treatments and prescription eye-care products helped the Irvine company weather ...

Recently, Allergan, Inc. (AGN) announced positive data from two phase III trials of Botox (onabotulinumtoxinA). The trials evaluated the drug in patients with idiopathic overactive bladder (:OAB ...

Allergan's cell line and manufacturing process is unique and proprietary, and Botox has other complexing proteins present as well as albumin. Competitors to Botox--like Dysport and Xeomin ...

As Pfizer PFE1.07%increase; green up pointing triangle prepares to close on its big merger, Allergan’s product portfolio looks as youthful as ever. Allergan reported fourth-quarter revenue from ...